Skip to content

Biogen BIIB SPINRAZA — Expensereflectedwithinstatementsofincome

Discontinued — last reported Q4 '18

Similar metrics at other companies

Bruker logo
BRKRBsi Biospin — Selling General And Administrative Expense
$41.8M+7.2%
Bruker logo
BRKRBsi Biospin — Research And Development Expense
$24.2M+10.0%
Bruker logo
BRKRBsi Biospin — Cost Of Segment Revenue
$102.7M-6.4%
Bruker logo
BRKRBsi Biospin — Segment Expenditure Addition To Long Lived Assets
$2.4M-25.0%
MetLife logo
METRIS — Direct and Allocated Expenses
$93M-5.1%
Dover logo
DOVEngineered Products — Adjusted selling, general and administrative expenses
$39.1M+4.4%

Other financials

Income statement

See full
Revenue$2.5B+1.9%
Gross profit$1.8B+0.8%
Operating income$610.7M
Net income$319.5M+32.8%
EPS (diluted)$2.15+31.1%

Balance sheet

See full
Cash & equivalents$3.4B+30.2%
Total debt$6.6B+34.7%
Total equity$18.7B+9.9%
Total assets$29.5B+5.2%

Cash flow

See full
Operating cash flow$645.5M+149%
CapEx$51.2M+38.0%
Free cash flow$594.3M+167%

Valuation

See full
Market cap$29.02B+34.3%
Enterprise value$32.2B+34.9%
P/E20.4×+5.8×
P/S2.9×+0.7×

Profitability

See full
Gross margin75.5%-0.1pp
Operating margin22.9%
Net margin14.3%-0.8pp
FCF margin24.4%-0.4pp

Returns & leverage

See full
Return on equity8%-1.2pp
Debt / equity0.4×+0.1×
Current ratio3.1×+1.6×

Where this comes from

Reported directly by Biogen in its filing.

Tagged under the XBRL concept biib:Expensereflectedwithinstatementsofincome.

The official record: Biogen’s 10-K, filed February 6, 2019, on SEC EDGAR. View the filing →

Questions, answered.

What does SPINRAZA — expensereflectedwithinstatementsofincome mean?
Operating expenses specifically attributable to the support, marketing, or administration of a particular product segment. This captures the direct overhead required to maintain the product's presence in the market.